Neurology

Experimental Agent Shows Promise in Slowing Genetic Form of ALS

Researchers successfully target elevated levels of a harmful protein, offering hope to people with a genetic form of amyotrophic lateral sclerosis.
Medscape Medical News

Source link




Related posts

neurosciencenews: Neurons that Fire Together, Don’t Always Wire…

Newsemia

Clinching the cause: A review of foot drop secondary to lumbar degenerative diseases.

Newsemia

Ethical, palliative, and policy considerations in disorders of consciousness

Newsemia

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy